Clinical Informatics for Diagnostic Stewardship
Hospitals typically rely on a standard antibiogram, published once a year with only general information about bacterial pathogens. The static report increases the risk of prescribing an inappropriate antibiotic, potentially exacerbating antimicrobial resistance. In the wake of COVID-19 and the anticipated impact it will have on antimicrobial resistance, being able to transform the antibiogram to be automated and dynamic, providing up-to-date information and real-time health data is needed more than ever to empower more informed clinical decision making. “When lives are at stake, speed to insight is crucial,” says John Hurst, PharmD, Director of Antimicrobial Stewardship at bioMérieux, Inc. bioMérieux’s innovative advanced analytics software application connects diagnostic data inside U.S. hospitals to provide vital lab and clinical data across departments, processes, and vendors, including regional surveillance of multi-drug resistant organisms. With this technology “Lab staff could focus on improving their quality and turnaround times. Infection control teams could get a better idea of what’s happening in their environments. Pharmacies could build the right formularies for antibiotics and measure the effectiveness of their stewardship initiatives,” Hurst continued.
To propel your stewardship efforts forward today and be better prepared for tomorrow, explore more about bioMérieux's clinical informatics to improve diagnostic and antimicrobial stewardship.